Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Omaha, Nebraska 68105


Purpose:

The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during the 9 week study. A final followup assessment will be conducted 6 months from the start of treatment.


Criteria:

Inclusion Criteria: - Currently a patient in the Omaha VA Medical Center, Substance Abuse Treatment Center (SATC) or at Catholic Charities Campus for Hope. - Have a diagnosis of alcohol abuse or alcohol dependence. - Smoke 20 or more cigarettes/day (may also smoke pipes/cigars). - Be interested in quitting smoking. - Provide name, addresses, and phone numbers of at least two individuals who can provide information on their alcohol, nicotine, and other drug use during the follow-up period. - If female, patient must a) be of non-childbearing potential, b) have a negative pregnancy test, c) sign a document stating they do not plan on becoming pregnant during the study. - Agree to sign informed consent. - Able to read and understand study-related forms and procedures. Exclusion Criteria: - Advanced cardiac, pulmonary, renal, or liver disease. - History of seizures. - History of brain tumor or significant head trauma. - History of bulimia or anorexia nervosa. - Current major depressive disorder or past history of panic disorders, schizophrenia, or bipolar affective disorder. - Using psychoactive drugs. - Receiving treatment with medications that lower seizure thresholds. - Use of an investigational drug in any study in the past four weeks. - Currently using any asthma medication. - Used time-released bupropion in the past 12 months. - Currently using any other treatments to stop smoking.


NCT ID:

NCT00044434


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Omaha, Nebraska 68105
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.